$545.91M
Revenue
$11.12M
Net Income
33.35%
Gross Margin
5.60%
Op. Margin
$-33.54M
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $99.95M | $161.90M | $172.64M | $111.42M | $87.27M | $150.50M | $160.12M |
| Revenue Growth % (YoY) | 14.5% | 7.6% | 7.8% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $72.01M | $104.60M | $108.68M | $78.54M | $65.83M | $101.81M | $107.10M |
| Gross Profit | $27.94M | $57.31M | $63.96M | $32.88M | $21.45M | $48.69M | $53.02M |
| Gross Margin % | 28.0% | 35.4% | 37.1% | 29.5% | 24.6% | 32.4% | 33.1% |
| Selling General & Admin | $31.42M | $28.59M | $31.94M | $30.62M | $27.19M | $28.34M | $26.59M |
| Operating Income | $-10.72M | $21.51M | $24.72M | $-4.93M | $-13.03M | $13.37M | $20.01M |
| Operating Margin % | -10.7% | 13.3% | 14.3% | -4.4% | -14.9% | 8.9% | 12.5% |
| Interest Expense | $6.25M | $20.73M | $14.68M | $6.27M | $4.41M | $20.48M | $16.13M |
| Other Income/Expense | $1.30M | $-1.17M | $3.05M | $308.00K | $-4.54M | $693.00K | $-804.00K |
| Income Before Tax | $-13.16M | $15.58M | $21.11M | $-10.04M | $-20.98M | $5.85M | $13.72M |
| Income Tax Expense | $-6.15M | $7.47M | $5.13M | $-4.08M | $8.19M | $-43.00K | $442.00K |
| Net Income | $-7.01M | $8.12M | $15.98M | $-5.96M | $-29.17M | $5.90M | $13.28M |
| Net Margin % | -7.0% | 5.0% | 9.3% | -5.4% | -33.4% | 3.9% | 8.3% |
| Basic EPS | nan | 0.07 | 0.14 | -0.05 | -0.25 | 0.05 | 0.12 |
| Diluted EPS | nan | 0.07 | 0.13 | -0.05 | -0.25 | 0.05 | 0.11 |
| Basic Shares Outstanding | 101K | 116.6M | 116.5M | 115.9M | 77K | 115.6M | 115.5M |
| Diluted Shares Outstanding | 101K | 119.9M | 119.4M | 115.9M | -1.7M | 118.4M | 117.0M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $71.04M | $70.52M | $26.94M | $23.97M | $56.40M | $59.86M | $90.77M |
| Accounts Receivable | $39.91M | $81.11M | $88.55M | $83.76M | $32.30M | $66.12M | $65.87M |
| Inventory | $74.93M | $70.32M | $78.65M | $86.86M | $77.10M | $74.94M | $83.67M |
| Other Current Assets | $20.94M | $9.41M | $11.34M | $8.36M | $8.54M | $9.37M | $9.43M |
| Total Current Assets | $219.00M | $240.91M | $214.37M | $211.54M | $178.30M | $217.84M | $251.38M |
| Property Plant & Equipment | $118.82M | $114.11M | $114.42M | $112.00M | $112.85M | $114.68M | $112.65M |
| Goodwill | $155.19M | $155.02M | $155.00M | $154.68M | $152.62M | $153.04M | $131.18M |
| Intangible Assets | $268.07M | $275.12M | $282.31M | $289.23M | $292.91M | $301.31M | $269.70M |
| Total Assets | $823.22M | $844.42M | $822.14M | $824.59M | $794.21M | $853.41M | $830.03M |
| Accounts Payable | $19.28M | - | - | $28.04M | $13.14M | - | - |
| Deferred Revenue | $4.33M | - | - | - | $3.79M | - | - |
| Other Current Liabilities | $48.98M | $59.47M | $53.52M | $44.64M | $47.41M | $50.73M | $41.69M |
| Total Current Liabilities | $79.14M | $99.22M | $89.87M | $83.03M | $70.98M | $89.38M | $78.14M |
| Long-term Debt | $279.84M | - | - | - | $281.52M | - | - |
| Deferred Tax Liabilities | $34.27M | $32.35M | $32.35M | $32.35M | $32.35M | $40.09M | $40.09M |
| Other Non-current Liabilities | $3.40M | $3.41M | $3.61M | $3.46M | $3.25M | $5.04M | $3.11M |
| Total Liabilities | $417.36M | $436.06M | $423.71M | $443.44M | $406.99M | $436.76M | $421.89M |
| Common Stock | $12.00K | $12.00K | $12.00K | $12.00K | $12.00K | $12.00K | $12.00K |
| Retained Earnings | $-63.69M | $-56.68M | $-64.80M | $-80.78M | $-74.82M | $-45.65M | $-51.54M |
| Total Stockholders Equity | $405.86M | $408.36M | $398.43M | $381.14M | $387.22M | $416.65M | $408.13M |
| Total Liabilities & Equity | $823.22M | $844.42M | $822.14M | $824.59M | $794.21M | $853.41M | $830.03M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $-7.01M | $8.12M | $10.02M | $-5.96M | $-29.17M | $5.90M | $5.42M |
| Depreciation & Amortization | $13.38M | $37.98M | $25.10M | $12.40M | $12.15M | $32.29M | $20.97M |
| Stock-based Compensation | $3.92M | $5.33M | $3.35M | $1.97M | $2.21M | $5.19M | $3.34M |
| Change in Receivables | $-41.13M | $50.35M | $57.45M | $52.55M | $-33.26M | $35.64M | $36.83M |
| Change in Inventory | $4.49M | $-7.33M | $900.00K | $9.56M | $2.82M | $-25.52M | $-13.14M |
| Change in Payables | $-10.49M | $16.30M | $13.07M | $14.27M | $-14.42M | $10.38M | $9.82M |
| Operating Cash Flow | $23.31M | $40.12M | $-10.90M | $-46.88M | $6.16M | $55.15M | $17.91M |
| Capital Expenditure | $9.22M | $16.16M | $10.34M | $3.45M | $6.25M | $13.86M | $9.83M |
| Acquisitions | - | $4.93M | $4.93M | $4.93M | $481.00K | $64.05M | - |
| Investing Cash Flow | $-21.23M | $-21.09M | $-15.28M | $-8.39M | $-6.74M | $-77.91M | $-9.83M |
| Financing Cash Flow | $-2.06M | $-4.92M | $-3.58M | $22.49M | $-1.82M | $-20.20M | $-20.00M |
| Net Change in Cash | $525.00K | $14.12M | $-29.45M | $-32.43M | $-3.46M | $-42.90M | $-11.99M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $161.90M | - | $445.96M | - |
| Cost of Revenue | $104.60M | - | $291.81M | - |
| Gross Profit | $57.31M | - | $154.15M | - |
| Selling General & Admin | $28.59M | - | $91.15M | - |
| Operating Income | $21.51M | - | $41.30M | - |
| Interest Expense | $6.07M | - | $20.73M | - |
| Other Income/Expense | $-1.17M | - | $2.19M | - |
| Income Before Tax | $15.58M | - | $26.65M | - |
| Income Tax Expense | $7.47M | - | $8.52M | - |
| Net Income | $8.12M | $13.28M | $18.14M | - |
| Basic EPS | 0.07 | - | 0.16 | - |
| Diluted EPS | 0.07 | - | 0.15 | - |
| Basic Shares Outstanding | $116.60M | - | $116.32M | - |
| Diluted Shares Outstanding | $119.91M | - | $119.72M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $70.52M | $56.40M |
| Accounts Receivable | $81.11M | $32.30M |
| Inventory | $70.32M | $77.10M |
| Other Current Assets | $9.41M | $8.54M |
| Total Current Assets | $240.91M | $178.30M |
| Property Plant & Equipment | $114.11M | $112.85M |
| Goodwill | $155.02M | $152.62M |
| Intangible Assets | $275.12M | $292.91M |
| Total Assets | $844.42M | $794.21M |
| Other Current Liabilities | $59.47M | $47.41M |
| Total Current Liabilities | $99.22M | $70.98M |
| Deferred Tax Liabilities | $32.35M | $32.35M |
| Other Non-current Liabilities | $3.41M | $3.25M |
| Total Liabilities | $436.06M | $406.99M |
| Common Stock | $12.00K | $12.00K |
| Retained Earnings | $-56.68M | $-74.82M |
| Total Stockholders Equity | $408.36M | $387.22M |
| Total Liabilities & Equity | $844.42M | $794.21M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $8.12M | $13.28M | $18.14M | - |
| Depreciation & Amortization | - | - | $37.98M | - |
| Stock-based Compensation | - | - | $5.33M | - |
| Change in Receivables | - | - | $50.35M | - |
| Change in Inventory | - | - | $-7.33M | - |
| Change in Payables | - | - | $16.30M | - |
| Operating Cash Flow | - | - | $40.12M | - |
| Capital Expenditure | - | - | $16.16M | - |
| Acquisitions | - | - | $4.93M | - |
| Investing Cash Flow | - | - | $-21.09M | - |
| Financing Cash Flow | - | - | $-4.92M | - |
| Net Change in Cash | - | - | $14.12M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.